Home
Dashboard
Curated content
Startups & Scaleups
Corporates
Investors
Funding rounds
Exits
Universities
Accelerators
Workspaces
Service providers
More organizations
Matching tool
Investment heatmap
Themes
Reports
Companies
BioStratum
Save
BioStratum
And commercializes therapeutic agents for the treatment of diabetes and diabetic complications.
Launch date
1994
Employees
2-10 people
Market cap
-
Enterprise valuation
$2—4m
(Dealroom.co estimates Aug 2011.)
Durham North Carolina (HQ)
http://biostratum.com
https://www.linkedin.com/company/biostratum-incorporated/
B2B
health
pharmaceutical
hard tech
biotechnology
biotech and pharma
oncology
diabetes
personal health
Overview
Similar companies
Investments (1)
Analytics
Notes
Job openings
Innovations (0)
BioStratum funding
BioStratum investors
Edit
Date
Investors
Amount
Round
Aug 2003
BankInvest
HealthCap
Equity Resources Group
$9.5m
Early VC
Aug 2011
N/A
$600k
Late VC
Total Funding
$10.1m
Related Content
Recent News about BioStratum
Edit
Tech stack
Group
Tech stack
Learn more about the technologies and tools that this company uses.
Login for access
Investments by BioStratum
Edit
NephroGenex
exited
